Thiotepa (Tepadina)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Thiotepa (Tepadina), covering 2025-06-11 to 2025-06-11. Get the full timeline:
Most recent: Clinical Trial Update: High-Dose Gemcitabine, Busulfan, and Thiotepa Followed by ASCT in Primary Central Nervous System Lymphoma [Phase 2]